home / stock / bio / bio news


BIO News and Press, Bio-Rad Laboratories Inc. Class A From 05/04/23

Stock Information

Company Name: Bio-Rad Laboratories Inc. Class A
Stock Symbol: BIO
Market: NYSE
Website: bio-rad.com

Menu

BIO BIO Quote BIO Short BIO News BIO Articles BIO Message Board
Get BIO Alerts

News, Short Squeeze, Breakout and More Instantly...

BIO - Bio-Rad Laboratories, Inc. (BIO) Q1 2023 Earnings Call Transcript

2023-05-04 22:48:02 ET Bio-Rad Laboratories, Inc. (BIO) Q1 2023 Results Conference Call May 04, 2023 05:00 PM ET Company Participants Ed Chung - Vice President, Investor Relations Norman Schwartz - Chief Executive Officer Ilan Daskal - Executive Vice President &a...

BIO - Bio-Rad Labs Non-GAAP EPS of $3.34 misses by $0.14, revenue of $676.8M misses by $12.48M

2023-05-04 17:28:10 ET Bio-Rad Labs press release ( NYSE: BIO ): Q1 Non-GAAP EPS of $3.34 misses by $0.14 . Revenue of $676.8M (-3.3% Y/Y) misses by $12.48M . Updated 2023 Financial Outlook Bio-Rad is updating its financial outlook for full-year 2023. The c...

BIO - Bio-Rad Reports First-Quarter 2023 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2023. First-quarter 2023 net sales were $676.8 million, a decrease of 3.3 percent compared to $70...

BIO - Thermo Fisher, Danaher among decliners as Sartorius disappoints with Q1

2023-04-20 10:14:49 ET Shares of Life Sciences tool makers Thermo Fisher Scientific ( TMO ), Danaher Corporation ( DHR ), Repligen ( RGEN ), and Bio-Rad Laboratories ( BIO ) came under pressure after their EU peer Sartorius ( OTCPK:SARTF ) disappointed with its Q1 2023 e...

BIO - Bio-Rad: Aggressively Buying In FY 2023

2023-04-13 11:12:23 ET Summary Bio-Rad is back on the table as an attractive value proposition once again. The firm is well-positioned to unlock tremendous value for shareholders looking ahead, in my estimation. Profitability is a standout, and the Sartorius equity position is...

BIO - Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the first quarter of 2023 on Thursday, May 4, 2023, following the close of the market. Management will discuss these results in a confe...

BIO - The 3 Most Promising Biotech Stocks to Buy Now

2023-03-21 09:00:58 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips This year the National Institutes of Health is set to request its biggest budget yet for 2024, on the heels of its previous biggest budget in 2023. As the COVID-19 pandemic fades from view, l...

BIO - I Asked ChatGPT for 10 EV Stocks to Buy. Here's What It Recommended.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nearly three months after the launch of OpenAI’s ChatGPT, investors remain hyper-focused on artificial intelligence ( AI ). There’s plenty of reason to be. Major companies are working around the clock to perfe...

BIO - Bio-Rad to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Confe...

BIO - Bio-Rad Laboratories, Inc. (BIO) Q4 2022 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (BIO) Q4 2022 Earnings Conference Call February 16, 2023 5:00 PM ET Company Participants Edward Chung - Vice President, Investor Relations Ilan Daskal - Chief Financial Officer Andrew Last - Chief Operating Officer Norman Schwartz - Presi...

Previous 10 Next 10